Multiomics approach identifies SERPINB1 as candidate biomarker for spinocerebellar ataxia type 2
Luis E. Almaguer-Mederos(Goethe University Frankfurt), Georg Auburger(Goethe University Frankfurt)
Cited by 3
Related Papers
Potentiation of neurotoxicity in double-mutant mice with Pink1 ablation and A53T-SNCA overexpression
|Human Molecular Genetics|2014|70
Methyl-Arginine Profile of Brain from Aged PINK1-KO+A53T-SNCA Mice Suggests Altered Mitochondrial Biogenesis
|Parkinson s Disease|2016|18